Arca
Skip to content
Tools
Tools

Radiculopathy

Drug research and approvals for radiculopathy: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 75 studies of radiculopathy are recruiting on ClinicalTrials.gov, and Health Canada has authorized 1 drug trials for it since 2013.

  • Recruiting worldwide: 75
  • Trials authorized in Canada: 1
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 75 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 6

Phase 2 5

  • DexamethasoneGlucocorticoid receptor agonist
  • VixotrigineSodium channel protein type IX alpha subunit blocker
  • EtanerceptTNF-alpha inhibitor
  • LenalidomideCRL4(CRBN) E3 ubiquitin ligase inhibitor
  • Z160Voltage-gated N-type calcium channel alpha-1B subunit blocker

Phase 1 or earlier 4

How its trials ended

383 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 60 whose ending is known, 22% met their primary endpoint, 10% missed it and 68% stopped early.

  • Completed, result not reported16944%
  • Ongoing9625%
  • Status unknown5815%
  • Stopped: other or unclear195%
  • Met its primary endpoint133%
  • Stopped: enrollment or feasibility123%
  • Missed its primary endpoint62%
  • Stopped: sponsor or business decision41%
  • Stopped: funding31%
  • Stopped: lack of efficacy21%
  • Stopped: safety1<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
AuthorizedTrialSponsorStatus
Apr 7, 2017Prospective, double-blind, randomized, multicenter phase III study evaluating efficacy and safety of three different dosages of newgam in patients with chronic…Newgam (PANZYGA)Octapharma Pharmazeutika Produktionsges M B HOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.